DASH
Repository logo
Communities & Collections
Browse DASH
DASH Stories
Statistics
  1. Home
  2. Harvard Division of Continuing Education
  3. DCE Theses and Dissertations
  4. The integration of antibody engineering with biomolecular interaction visualization tools for the reduction of sequence liabilities in the generation of therapeutic antibodies

The integration of antibody engineering with biomolecular interaction visualization tools for the reduction of sequence liabilities in the generation of therapeutic antibodies

Open/View files
Harvard Thesis Christine Feulner Final Updates.pdf (4.73 MB)
Date
October 1, 2024
Author(s)
Feulner, Christine J
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Feulner, Christine J. 2024. The integration of antibody engineering with biomolecular interaction visualization tools for the reduction of sequence liabilities in the generation of therapeutic antibodies. Master's thesis, Harvard University Division of Continuing Education.
Abstract
Monoclonal antibodies are a biological treatment option for hematological cancers that utilize both innovative modalities in conjunction with the function of the immune system. However, limitations with monoclonal antibodies from sequence liabilities in the binding domains can influence stability and manufacturing capabilities. The use of biomolecular interaction visualization tools may offer a theoretical method to modify known sequence liabilities from the binding domains of monoclonal antibodies with little effect on the overall structure and function of the antibody. To investigate this process, two antibodies of interest were selected, and the corresponding antibody sequences were analyzed using a biomolecular interaction visualization tool, altering the observed sequence liabilities. These modifications were assessed using antibody production and binding studies as a single monoclonal antibody, then as a bispecific antibody. A final set of bispecific antibodies were characterized by cell-based binding studies, confirming binding to corresponding cell lines at similar levels as the parental antibody sequences.
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service
URI
https://nrs.harvard.edu/URN-3:HUL.INSTREPOS:37379595
Subjects

bioengineering

biomolecular interact...

bispecific antibody

monoclonal antibody

Bioengineering

Nanotechnology

Collection
DCE Theses and Dissertations
Metrics
Repository logo
  • CONTACT US
  • OSRDS
  • ABOUT DASH
  • DEPOSITING TO DASH
  • TERMS OF USE
  • REQUEST A WAIVER
  • TAKE DOWN POLICY
  • NAME CHANGE POLICY
  • HARVARD OA POLICIES
  • DASH SUBMITTER AGREEMENT
  • Accessibility
  • Privacy
Creative Commons License BY
Creative Commons Attribution 4.0 International License

Except where otherwise noted, this work is subject to a Creative Commons Attribution 4.0 International License,
which allows anyone to share and adapt our material as long as proper attribution is given.
For details and exceptions, see the Harvard Library Copyright Policy
©2024 Presidents and Fellows of Harvard College.